| Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial D Rischin, RJ Young, R Fisher, SB Fox, QT Le, LJ Peters, B Solomon, ... Journal of clinical oncology 28 (27), 4142, 2010 | 868 | 2010 |
| Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments B Solomon, RJ Young, D Rischin Seminars in cancer biology 52, 228-240, 2018 | 369 | 2018 |
| Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell … RJ Young, K Waldeck, C Martin, JH Foo, DP Cameron, L Kirby, H Do, ... Pigment cell & melanoma research 27 (4), 590-600, 2014 | 204 | 2014 |
| Comparison of four PD-L1 immunohistochemical assays in lung cancer S Hendry, DJ Byrne, GM Wright, RJ Young, S Sturrock, WA Cooper, ... Journal of Thoracic Oncology 13 (3), 367-376, 2018 | 156 | 2018 |
| The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma R Ramsdale, RN Jorissen, FZ Li, S Al-Obaidi, T Ward, KE Sheppard, ... Science signaling 8 (390), ra82-ra82, 2015 | 135 | 2015 |
| Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma B Solomon, RJ Young, M Bressel, D Urban, S Hendry, A Thai, C Angel, ... Cancer immunology research 6 (3), 295-304, 2018 | 118 | 2018 |
| Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma RJ Young, D Rischin, R Fisher, GA McArthur, SB Fox, LJ Peters, J Corry, ... Cancer epidemiology, biomarkers & prevention 20 (6), 1230-1237, 2011 | 114 | 2011 |
| Frequency and prognostic significance of p16INK4A protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma RJ Young, D Urban, C Angel, J Corry, B Lyons, N Vallance, S Kleid, ... British journal of cancer 112 (6), 1098-1104, 2015 | 113 | 2015 |
| Glomerular size and glomerulosclerosis in Australian aborigines RJ Young, WE Hoy, P Kincaid-Smith, AE Seymour, JF Bertram American journal of kidney diseases 36 (3), 481-489, 2000 | 76 | 2000 |
| Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome AM Lim, H Do, RJ Young, SQ Wong, C Angel, M Collins, EA Takano, ... International journal of cancer 135 (4), 887-895, 2014 | 74 | 2014 |
| Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence MD Hughson, K Johnson, RJ Young, WE Hoy, JF Bertram American journal of kidney diseases 39 (4), 679-688, 2002 | 72 | 2002 |
| Identification of P450 oxidoreductase as a major determinant of sensitivity to hypoxia-activated prodrugs FW Hunter, RJ Young, Z Shalev, RN Vellanki, J Wang, Y Gu, N Joshi, ... Cancer Research 75 (19), 4211-4223, 2015 | 70 | 2015 |
| In vitro studies on the roles of transforming growth factor-β1 in rat metanephric development AT Clark, RJ Young, JF Bertram Kidney international 59 (5), 1641-1653, 2001 | 65 | 2001 |
| Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer QT Le, R Fisher, KS Oliner, RJ Young, H Cao, C Kong, E Graves, ... Clinical Cancer Research 18 (6), 1798-1807, 2012 | 63 | 2012 |
| Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance CA Martin, C Cullinane, L Kirby, S Abuhammad, EJ Lelliott, K Waldeck, ... International Journal of Cancer 142 (10), 2139-2152, 2018 | 61 | 2018 |
| Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling IA Vergara, CP Mintoff, S Sandhu, L McIntosh, RJ Young, SQ Wong, ... Nature communications 12 (1), 1434, 2021 | 56 | 2021 |
| Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial AM Lim, D Rischin, R Fisher, H Cao, K Kwok, D Truong, GA McArthur, ... Clinical cancer research 18 (1), 301-307, 2012 | 55 | 2012 |
| p16‐positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: no association with high‐risk human papillomavirus or prognosis and implications for … LJ McDowell, RJ Young, ML Johnston, TJ Tan, S Kleid, CS Liu, M Bressel, ... Cancer 122 (8), 1201-1208, 2016 | 52 | 2016 |
| A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma J Lewin, KK Khamly, RJ Young, C Mitchell, RJ Hicks, GC Toner, ... British journal of cancer 111 (12), 2254-2261, 2014 | 50 | 2014 |
| The role of human papillomavirus in p16‐positive oral cancers S Belobrov, AM Cornall, RJ Young, K Koo, C Angel, D Wiesenfeld, ... Journal of oral pathology & medicine 47 (1), 18-24, 2018 | 48 | 2018 |
Danny RischinPeter MacCallum Cancer CentreVerified email at petermac.org
